Definitive Contract 75N91019C00029
- Not listed
- This is a $1,997,803 firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Cell Microsystems Inc., a small business manufacturer of specialized biomedical research equipment and tools. The contract is for the topic "Integrated Imaging and Molecular Analysis of Glioblastoma Using SCOPE SEQ on the Air Flow" and has a total small business set-aside designation. The contract will support...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Cell Microsystems Inc., a for-profit manufacturer of biomedical research equipment and supplies. The $205,600.00 contract is for the delivery of the CELLRAFT air system and CYTOSORT 100 instrument, which support various research applications such as gene editing, cancer research, and immunology. The contract does not have a set-aside designation. Cell...
- This is a $100,000.00 firm fixed price purchase order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Nanocellect Biomedical Inc., a small business, for a small sized cell sorter with single cell dispenser. The award was made on August 6, 2018 with an ultimate completion date of August 5, 2019. Nanocellect Biomedical has provided cell sorting systems and related services to various federal agencies, and this contract supports the company's...
- This is a $1,648,645.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Cell Microsystems Inc. under the Small Business Innovation Research (SBIR) Phase II program. The purpose of this contract is to focus on developing a T-cell activation protocol consistent with reporter cell viability, creating a proprietary reporter cell line, and gathering and benchmarking...
- This federal contract award is for the procurement of a Celigo S Imaging Cytometer System from Nexcelom Bioscience LLC, a for-profit limited liability company that develops and markets image cytometry products for life science and biomedical research. The contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), for $115,000.00 on a firm fixed-price basis. The original solicitation was...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Celartia, Inc., a small disadvantaged business, for the development of a fully automated system for cell therapy processing. The contract has a period of performance from September 13, 2021 to June 12, 2022 and a ceiling value of $393,312. The contract was awarded under a total small business set-aside. The original...
- This is a $198,641 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI) to Nanocellect Biomedical Inc., a for-profit biotechnology company. The contract is for the development of a "CTC Label and Capture by Lab-on-a-Chip Flow-Cytometry" solution, which aligns with the NCI's research interests. Nanocellect Biomedical is an innovative provider of automated cell analysis, sorting, and dispensing equipment and services, with a strong...
- This is a firm-fixed price purchase order awarded by the Department of Health and Human Services' National Cancer Institute (NCI) to Nexcelom Bioscience LLC, a small business, for a Celigo Image Cytometer System. The $159,000 contract supports the NCI's Transplantation Therapy Section within the Experimental Transplantation and Immunology Branch, which focuses on research related to T cell homeostasis, repertoire, function, and regeneration in a transplantation setting. The Celigo system will...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Micromics Technologies LLC for the development of an "Integrated Platform for In-Depth Single-Cell Proteomics". The contract has a performance period from September 13, 2021 to June 12, 2022 and a ceiling value of $455,000. It is a firm fixed-price definitive contract set aside for small businesses. The original...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Nanocellect Biomedical Inc., a for-profit biotechnology company. The $199,743 firm-fixed-price contract is for the development of a "Portable Multiplex Analysis System" called "Flownostics" under Topic 309. The contract is set aside for small businesses. Nanocellect Biomedical has a history of providing...
This is a Firm Fixed Price contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Cell Microsystems Inc., a small business manufacturer of tools for imaging, sorting, and isolating single cells and colonies. The $2,295,432.00 contract, which is part of the Small Business Innovation Research (SBIR) program, supports the integration of Cell Microsystems' SCOPE SEQ technology with air flow capabilities for the molecular analysis of glioblastoma, an aggressive type of brain cancer. The work is being performed in Research Triangle Park, North Carolina. This award builds on Cell Microsystems' previous NIH-funded research and development efforts focused on advancing technologies for gene editing, cancer research, stem cell biology, immunology, and other life science applications.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Nanoparticle Delivery of HIV Env Trimer for Inducing Somatic Hypermutation and bNAb | PHS-2019-1 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Award Notice 1/1 | 6/29/18, 8:32 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | $0 | 8/19/22 | |
| P00002 | Change Order | $0 | 5/27/20 | |
| P00001 | Other Administrative Action | $0 | 11/26/19 | |
| Not listed | Not listed | $297.6k | 9/6/19 |